Trypanosoma cruzi: Possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs

About 200 clinically used amphiphilic cationic drugs have been shown to be active in vitro against Trypanosoma cruzi at concentrations of ⩽ 1 m M. Activity against epimastigote and trypomastigote forms was similar, and in both cases the most potent drugs were litracene, maprotiline, thioproperazine,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental parasitology 1985-01, Vol.60 (1), p.32-42
Hauptverfasser: Hammond, David J., Hogg, Janet, Gutteridge, Winston E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 42
container_issue 1
container_start_page 32
container_title Experimental parasitology
container_volume 60
creator Hammond, David J.
Hogg, Janet
Gutteridge, Winston E.
description About 200 clinically used amphiphilic cationic drugs have been shown to be active in vitro against Trypanosoma cruzi at concentrations of ⩽ 1 m M. Activity against epimastigote and trypomastigote forms was similar, and in both cases the most potent drugs were litracene, maprotiline, thioproperazine, and the acridines: acranil, aminacrine, and mepacrine. Fluorescence microscopy demonstrated that epimastigotes rapidly accumulate acridines initially in discrete subcellular organelles. The amount of drug incorporated during 15 min of incubation was sufficient to produce subsequent lysis of both trypomastigotes and epimastigotes within 24 hr at 4 C. Trypanocidal activity was dependent on the extracellular pH (optimum ⩾ 8) and drug exposure time, but was independent of red blood cell density, serum dilution, and temperature (4 to 37 C). Despite their trypanocidal activity, amphiphilic cationic drugs appear to have no significant effect on the energy state of red blood cells at a concentration of 1 m M. These drugs have a possible role in the prevention of Chagas' disease by blood transfusion.
doi_str_mv 10.1016/S0014-4894(85)80020-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76215945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014489485800205</els_id><sourcerecordid>14403503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-2977bb015fd3edf4fbd7b146d741a762e57b94336d766297ac9410209e52a8bd3</originalsourceid><addsrcrecordid>eNqFkdtKHTEUhkOp2F3bRxByUYq9mLpympn0RkTUFgQF7XXIaWzKzGSazBS2T2_2gX0rhCSs9a0D_4_QKYHvBEh9_ghAeMVbyc9a8a0FoFCJd2hFQEJFOZfv0eqAfEAfc_4LAC2h_BgdM0lrwWCF0lNaT3qMOQ4a27S8hB_4IeYcTO-xjeOcYo9jhyeddA6zx3PSYx5CIeKIzRqbPka3i3bLNlju8RnrYfoTyumDxVbPJVE-Li3P-RM66nSf_ef9e4J-31w_Xf2s7u5vf11d3lWWU5grKpvGGCCic8y7jnfGNYbw2jWc6KamXjRGcsZKoK4LrK3kpIggvaC6NY6doK-7vlOK_xafZ1XWtr7v9ejjklXpQYTk4k2QcA5MACug2IE2FYmS79SUwqDTWhFQG1PU1hS1UVy1Qm1NUZsBp_sBixm8O1TtXSj5L_u8zlb3XRHThnzAWs4kYbRgFzvMF9X-B59UtsGP1ruQvJ2Vi-GNRV4BHyuqhQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14403503</pqid></control><display><type>article</type><title>Trypanosoma cruzi: Possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hammond, David J. ; Hogg, Janet ; Gutteridge, Winston E.</creator><creatorcontrib>Hammond, David J. ; Hogg, Janet ; Gutteridge, Winston E.</creatorcontrib><description>About 200 clinically used amphiphilic cationic drugs have been shown to be active in vitro against Trypanosoma cruzi at concentrations of ⩽ 1 m M. Activity against epimastigote and trypomastigote forms was similar, and in both cases the most potent drugs were litracene, maprotiline, thioproperazine, and the acridines: acranil, aminacrine, and mepacrine. Fluorescence microscopy demonstrated that epimastigotes rapidly accumulate acridines initially in discrete subcellular organelles. The amount of drug incorporated during 15 min of incubation was sufficient to produce subsequent lysis of both trypomastigotes and epimastigotes within 24 hr at 4 C. Trypanocidal activity was dependent on the extracellular pH (optimum ⩾ 8) and drug exposure time, but was independent of red blood cell density, serum dilution, and temperature (4 to 37 C). Despite their trypanocidal activity, amphiphilic cationic drugs appear to have no significant effect on the energy state of red blood cells at a concentration of 1 m M. These drugs have a possible role in the prevention of Chagas' disease by blood transfusion.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1016/S0014-4894(85)80020-5</identifier><identifier>PMID: 3926530</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Aminoacridines - metabolism ; Aminoacridines - pharmacology ; Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiparasitic agents ; Antiprotozoal Agents - metabolism ; Antiprotozoal Agents - pharmacology ; Biological and medical sciences ; Cations - metabolism ; Cations - pharmacology ; Chagas Disease - prevention &amp; control ; Chagas Disease - transmission ; Cytoplasm - drug effects ; Energy Metabolism - drug effects ; Erythrocytes - drug effects ; Erythrocytes - metabolism ; Human protozoal diseases ; Humans ; Infectious diseases ; Medical sciences ; Mice ; Mice, Inbred A ; Microscopy, Fluorescence ; Parasitic diseases ; Pharmacology. Drug treatments ; Protozoal diseases ; Time Factors ; Transfusion Reaction ; Tropical medicine ; Trypanosoma cruzi ; Trypanosoma cruzi - drug effects ; Trypanosoma cruzi - metabolism ; Trypanosoma cruzi - ultrastructure ; Trypanosomiasis</subject><ispartof>Experimental parasitology, 1985-01, Vol.60 (1), p.32-42</ispartof><rights>1985 Academic Press, Inc. All rights reserved</rights><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-2977bb015fd3edf4fbd7b146d741a762e57b94336d766297ac9410209e52a8bd3</citedby><cites>FETCH-LOGICAL-c420t-2977bb015fd3edf4fbd7b146d741a762e57b94336d766297ac9410209e52a8bd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014489485800205$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8439132$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3926530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hammond, David J.</creatorcontrib><creatorcontrib>Hogg, Janet</creatorcontrib><creatorcontrib>Gutteridge, Winston E.</creatorcontrib><title>Trypanosoma cruzi: Possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>About 200 clinically used amphiphilic cationic drugs have been shown to be active in vitro against Trypanosoma cruzi at concentrations of ⩽ 1 m M. Activity against epimastigote and trypomastigote forms was similar, and in both cases the most potent drugs were litracene, maprotiline, thioproperazine, and the acridines: acranil, aminacrine, and mepacrine. Fluorescence microscopy demonstrated that epimastigotes rapidly accumulate acridines initially in discrete subcellular organelles. The amount of drug incorporated during 15 min of incubation was sufficient to produce subsequent lysis of both trypomastigotes and epimastigotes within 24 hr at 4 C. Trypanocidal activity was dependent on the extracellular pH (optimum ⩾ 8) and drug exposure time, but was independent of red blood cell density, serum dilution, and temperature (4 to 37 C). Despite their trypanocidal activity, amphiphilic cationic drugs appear to have no significant effect on the energy state of red blood cells at a concentration of 1 m M. These drugs have a possible role in the prevention of Chagas' disease by blood transfusion.</description><subject>Aminoacridines - metabolism</subject><subject>Aminoacridines - pharmacology</subject><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiparasitic agents</subject><subject>Antiprotozoal Agents - metabolism</subject><subject>Antiprotozoal Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cations - metabolism</subject><subject>Cations - pharmacology</subject><subject>Chagas Disease - prevention &amp; control</subject><subject>Chagas Disease - transmission</subject><subject>Cytoplasm - drug effects</subject><subject>Energy Metabolism - drug effects</subject><subject>Erythrocytes - drug effects</subject><subject>Erythrocytes - metabolism</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred A</subject><subject>Microscopy, Fluorescence</subject><subject>Parasitic diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Protozoal diseases</subject><subject>Time Factors</subject><subject>Transfusion Reaction</subject><subject>Tropical medicine</subject><subject>Trypanosoma cruzi</subject><subject>Trypanosoma cruzi - drug effects</subject><subject>Trypanosoma cruzi - metabolism</subject><subject>Trypanosoma cruzi - ultrastructure</subject><subject>Trypanosomiasis</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkdtKHTEUhkOp2F3bRxByUYq9mLpympn0RkTUFgQF7XXIaWzKzGSazBS2T2_2gX0rhCSs9a0D_4_QKYHvBEh9_ghAeMVbyc9a8a0FoFCJd2hFQEJFOZfv0eqAfEAfc_4LAC2h_BgdM0lrwWCF0lNaT3qMOQ4a27S8hB_4IeYcTO-xjeOcYo9jhyeddA6zx3PSYx5CIeKIzRqbPka3i3bLNlju8RnrYfoTyumDxVbPJVE-Li3P-RM66nSf_ef9e4J-31w_Xf2s7u5vf11d3lWWU5grKpvGGCCic8y7jnfGNYbw2jWc6KamXjRGcsZKoK4LrK3kpIggvaC6NY6doK-7vlOK_xafZ1XWtr7v9ejjklXpQYTk4k2QcA5MACug2IE2FYmS79SUwqDTWhFQG1PU1hS1UVy1Qm1NUZsBp_sBixm8O1TtXSj5L_u8zlb3XRHThnzAWs4kYbRgFzvMF9X-B59UtsGP1ruQvJ2Vi-GNRV4BHyuqhQ</recordid><startdate>19850101</startdate><enddate>19850101</enddate><creator>Hammond, David J.</creator><creator>Hogg, Janet</creator><creator>Gutteridge, Winston E.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>19850101</creationdate><title>Trypanosoma cruzi: Possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs</title><author>Hammond, David J. ; Hogg, Janet ; Gutteridge, Winston E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-2977bb015fd3edf4fbd7b146d741a762e57b94336d766297ac9410209e52a8bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Aminoacridines - metabolism</topic><topic>Aminoacridines - pharmacology</topic><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiparasitic agents</topic><topic>Antiprotozoal Agents - metabolism</topic><topic>Antiprotozoal Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cations - metabolism</topic><topic>Cations - pharmacology</topic><topic>Chagas Disease - prevention &amp; control</topic><topic>Chagas Disease - transmission</topic><topic>Cytoplasm - drug effects</topic><topic>Energy Metabolism - drug effects</topic><topic>Erythrocytes - drug effects</topic><topic>Erythrocytes - metabolism</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred A</topic><topic>Microscopy, Fluorescence</topic><topic>Parasitic diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Protozoal diseases</topic><topic>Time Factors</topic><topic>Transfusion Reaction</topic><topic>Tropical medicine</topic><topic>Trypanosoma cruzi</topic><topic>Trypanosoma cruzi - drug effects</topic><topic>Trypanosoma cruzi - metabolism</topic><topic>Trypanosoma cruzi - ultrastructure</topic><topic>Trypanosomiasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hammond, David J.</creatorcontrib><creatorcontrib>Hogg, Janet</creatorcontrib><creatorcontrib>Gutteridge, Winston E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hammond, David J.</au><au>Hogg, Janet</au><au>Gutteridge, Winston E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trypanosoma cruzi: Possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>1985-01-01</date><risdate>1985</risdate><volume>60</volume><issue>1</issue><spage>32</spage><epage>42</epage><pages>32-42</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>About 200 clinically used amphiphilic cationic drugs have been shown to be active in vitro against Trypanosoma cruzi at concentrations of ⩽ 1 m M. Activity against epimastigote and trypomastigote forms was similar, and in both cases the most potent drugs were litracene, maprotiline, thioproperazine, and the acridines: acranil, aminacrine, and mepacrine. Fluorescence microscopy demonstrated that epimastigotes rapidly accumulate acridines initially in discrete subcellular organelles. The amount of drug incorporated during 15 min of incubation was sufficient to produce subsequent lysis of both trypomastigotes and epimastigotes within 24 hr at 4 C. Trypanocidal activity was dependent on the extracellular pH (optimum ⩾ 8) and drug exposure time, but was independent of red blood cell density, serum dilution, and temperature (4 to 37 C). Despite their trypanocidal activity, amphiphilic cationic drugs appear to have no significant effect on the energy state of red blood cells at a concentration of 1 m M. These drugs have a possible role in the prevention of Chagas' disease by blood transfusion.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>3926530</pmid><doi>10.1016/S0014-4894(85)80020-5</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4894
ispartof Experimental parasitology, 1985-01, Vol.60 (1), p.32-42
issn 0014-4894
1090-2449
language eng
recordid cdi_proquest_miscellaneous_76215945
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Aminoacridines - metabolism
Aminoacridines - pharmacology
Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiparasitic agents
Antiprotozoal Agents - metabolism
Antiprotozoal Agents - pharmacology
Biological and medical sciences
Cations - metabolism
Cations - pharmacology
Chagas Disease - prevention & control
Chagas Disease - transmission
Cytoplasm - drug effects
Energy Metabolism - drug effects
Erythrocytes - drug effects
Erythrocytes - metabolism
Human protozoal diseases
Humans
Infectious diseases
Medical sciences
Mice
Mice, Inbred A
Microscopy, Fluorescence
Parasitic diseases
Pharmacology. Drug treatments
Protozoal diseases
Time Factors
Transfusion Reaction
Tropical medicine
Trypanosoma cruzi
Trypanosoma cruzi - drug effects
Trypanosoma cruzi - metabolism
Trypanosoma cruzi - ultrastructure
Trypanosomiasis
title Trypanosoma cruzi: Possible control of parasite transmission by blood transfusion using amphiphilic cationic drugs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T21%3A39%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trypanosoma%20cruzi:%20Possible%20control%20of%20parasite%20transmission%20by%20blood%20transfusion%20using%20amphiphilic%20cationic%20drugs&rft.jtitle=Experimental%20parasitology&rft.au=Hammond,%20David%20J.&rft.date=1985-01-01&rft.volume=60&rft.issue=1&rft.spage=32&rft.epage=42&rft.pages=32-42&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1016/S0014-4894(85)80020-5&rft_dat=%3Cproquest_cross%3E14403503%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14403503&rft_id=info:pmid/3926530&rft_els_id=S0014489485800205&rfr_iscdi=true